Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership $16.92 +0.01 (+0.06%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$16.92 0.00 (0.00%) As of 01/31/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.59%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$12.77 M Get CNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNTA Insider Buying and Selling by Quarter Centessa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/27/2025Gregory M WeinhoffInsiderSell11,742$16.47$193,390.74 1/21/2025Saurabh SahaCEOSell55,000$15.77$867,350.00 1/15/2025Iqbal J HussainGeneral CounselSell6,000$15.29$91,740.00 12/26/2024Gregory M WeinhoffInsiderSell10,000$17.04$170,400.00 12/20/2024Saurabh SahaCEOSell55,000$17.44$959,200.00 12/17/2024Karen M AndersonInsiderSell10,624$17.32$184,007.68 12/17/2024Tia L BushCTOSell17,813$18.00$320,634.00 12/16/2024Iqbal J HussainGeneral CounselSell77,705$16.39$1,273,584.95 12/13/2024Karen M AndersonInsiderSell5,876$17.01$99,950.76 12/6/2024Saurabh SahaCEOSell87,496$18.46$1,615,176.16 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/25/2024Gregory M WeinhoffInsiderSell10,000$17.66$176,600.00 11/25/2024Saurabh SahaCEOSell299$18.23$5,450.77 11/22/2024Saurabh SahaCEOSell1,671$18.24$30,479.04 11/20/2024Saurabh SahaCEOSell55,000$16.89$928,950.00 10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96 10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44 10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00 9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11 9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00 9/10/2024Saurabh SahaCEOSell175,000$16.52$2,891,000.00 9/9/2024Gregory M WeinhoffInsiderSell25,000$15.00$375,000.00 8/22/2024Gregory M WeinhoffInsiderSell12,198$12.17$148,449.66 8/22/2024Saurabh SahaCEOSell506$12.23$6,188.38 8/20/2024Saurabh SahaCEOSell4,169$12.32$51,362.08 3/25/2024Karen M AndersonInsiderSell51,160$11.88$607,780.80 2/1/2024Harris RotmanSVPSell4,267$8.10$34,562.70 (Data available from 1/1/2013 forward) CNTA Insider Trading Activity - Frequently Asked Questions Who is on Centessa Pharmaceuticals's Insider Roster? The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA. What percentage of Centessa Pharmaceuticals stock is owned by insiders? 11.59% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings. Which Centessa Pharmaceuticals insiders have been selling company stock? The following insiders have sold CNTA shares in the last 24 months: Antoine Yver ($58,981.00), Gregory M Weinhoff ($1,505,184.47), Harris Rotman ($270,337.06), Iqbal J Hussain ($1,365,324.95), Karen M Anderson ($891,739.24), Saurabh Saha ($8,654,854.87), and Tia L Bush ($356,474.00). How much insider selling is happening at Centessa Pharmaceuticals? Insiders have sold a total of 843,468 Centessa Pharmaceuticals shares in the last 24 months for a total of $13,102,895.59 sold. Centessa Pharmaceuticals Key ExecutivesDr. Saurabh Saha M.D. (Age 48)Ph.D., CEO & Director Compensation: $1.04MDr. David M. Chao Ph.D. (Age 56)Chief Administrative Officer Compensation: $710.3kMr. John J. Crowley CPA (Age 50)CFO and Principal Financial & Accounting Officer Ms. Tia L. Bush (Age 53)Chief Technology & Quality Officer 1 recent tradesMs. Kristen K. Sheppard Esq.J.D., Senior Vice President of Investor Relations & Corporate CommunicationsMr. Iqbal J. Hussain L.L.B. (Age 43)General Counsel, Chief Compliance Officer & Corporate Secretary 2 recent tradesMs. Karen M. Anderson (Age 56)Chief People Officer 2 recent tradesDr. Gregory M. Weinhoff M.B.A. (Age 53)M.D., Chief Business Officer Compensation: $655kDr. Mario Alberto Accardi Ph.D.President of the Orexin ProgramMs. April DovholukSenior Vice President of Development Operations More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Transactions Blueprint Medicines Insider Transactions BridgeBio Pharma Insider Transactions Revolution Medicines Insider Transactions Lantheus Insider Transactions Elanco Animal Health Insider Transactions Cytokinetics Insider Transactions Nuvalent Insider Transactions Grifols Insider Transactions Axsome Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:CNTA) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.